We conclude that despite its activity on other kinases, UCN-1 treatment phenocopies the genetic depletion experiments in AML cells, suggesting that UCN-1 induced cell death in these cells is primarily a result of STK3 inhibition. The gene discussed is STK3; the disease is acute myeloid leukemia.